FIELD: chemistry.
SUBSTANCE: in arylpiperazinyl compounds of general formula , where R1 is unsubstituted alkyl or cycloalkyl; R2 and R3 independently hydrogen; lower alkyl; cycloalkyl; or -NR4R5, where R4 and R5 independently represent H, O, R6 or COR6, where R6 can represent lower alkyl or sulfonamidoalkyl; on condition that R2 and R3 both are not hydrogen; -atoms designated as bound with dotted line, taken together with atoms, to which they are joined, can form six-member ring; - Z represents N or C; - m equals 0, 1 or 2; - n equals 1, 2, 3, 4, 5 or 6; - p equals 0, 1, 2, 3 or 4. Compounds can be used for treatment of diseases, mediated directly or indirectly by 5-HT receptors. Such diseases are disorders of central nervous system.
EFFECT: increase of composition and method of treatment efficiency.
50 cl, 12 dwg, 2 tbl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE AND QUINAZOLINE DERIVATIVES WITH AFFINITY TO 5HT-RECEPTORS | 2004 |
|
RU2402533C2 |
DERIVATIVES OF HETEROARENE CARBOXAMIDE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2003 |
|
RU2320656C2 |
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
ALKALOID DERIVATIVES BASED ON AMINOESTERS AND COMPOSITIONS OF MEDICATIONS CONTAINING THEM | 2011 |
|
RU2580835C2 |
QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2544530C2 |
BENZENE OR THIOPHEN DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2526256C2 |
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
Authors
Dates
2008-11-27—Published
2004-02-02—Filed